Selective Neutral Sphingomyelinase-2 Inhibition Therapy
🧬 SMPD3
🏥 neurodegeneration
✅ 0.00
✨ 0.00
💥 0.00
This hypothesis proposes selective pharmacological inhibition of neutral sphingomyelinase-2 (nSMase2, encoded by SMPD3) to prevent pathological cerami...